Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Second Affiliated Hospital Of Guangzhou Medical University

Clinical trials sponsored by Second Affiliated Hospital Of Guangzhou Medical University, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a heart drug tame sepsis? new trial aims to find out Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 4 Not yet recruiting 1 Completed 1

Can a triple attack shrink untreatable liver tumors?

Disease control Completed

This trial is testing whether combining a procedure that blocks blood flow to tumors (TACE) with two drugs—sintilimab, which boosts the immune system, and bevacizumab, which cuts off tumor blood supply—can safely and effectively treat liver cancer that cannot be surgically remove…

Phase 1 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC